MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them ...

Using the gene-editing tool known as Crispr, the scientists knocked out these genes in tomatoes and found that glucose and ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Swiss CDMO Lonza is bulking up its bioconjugation manufacturing digs with two new multicustomer suites and 200 new jobs at ...

Salim Syed’s rating is based on a combination of encouraging developments surrounding Crispr Therapeutics AG. Firstly, the pricing of Casgevy in Saudi Arabia appears to be around $2 million per ...

FDA clearance of HG202 marks a significant milestone for CRISPR/Cas13 RNA-editing in clinical applications for nAMD. The ...